Composite tea solid beverage with effects of reducing blood sugar and blood fat as well as preparation method and application of composite tea solid beverage
By mixing Lu'an melon slices, cassia seeds and wolfberry in a specific proportion and preparing them into a compound tea solid beverage, the lack of research on the use of medicinal and food herbs in lowering blood sugar and blood lipids was solved, and better glycolipid metabolism was achieved The effect of disorder prevention and control provides a natural and safe food and health care product.
Patent Information
- Application Number
- CN202411031703.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-19
Smart Images

Figure CN118975613A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of compound tea beverages, and in particular to a compound tea solid beverage with blood sugar and lipid lowering effects, and a preparation method and application thereof. Background Art
[0002] Glucose and lipid metabolism is an important life process for the body's energy and material sources, and its homeostatic balance is an important prerequisite for the body to cope with changes in the internal and external environment. On the contrary, when its homeostatic imbalance occurs, it will induce type 2 diabetes, non-alcoholic fatty liver, hyperlipidemia, obesity and other major metabolic diseases that seriously threaten human health. Studies have shown that pathological mechanisms such as neuroendocrine axis dysfunction, insulin resistance, oxidative stress, chronic inflammatory response and intestinal microbiota imbalance can induce the above-mentioned chronic diseases of glucose and lipid metabolism disorders. Among them, non-alcoholic fatty liver disease, as a typical disease of glucose and lipid metabolism disorders, has risen to an epidemic level, posing a serious threat to human health.
[0003] Green tea (GT), as an unfermented tea, is well-loved by people. The catechin with the highest content in green tea is epigallocatechin gallate (EGCG), which has been shown to have many health benefits, such as in weight control and prevention of diabetes. Green tea and its components can prevent and improve the basic metabolic disorders induced by a high-fat diet. Although the treatments of dose, route and intervention time of these studies vary, green tea and its components can significantly improve blood biochemical characteristics and liver histological parameters compared with the control group, and alleviate liver lipid accumulation to varying degrees. In humans, epidemiological studies have shown that long-term consumption of GT may be associated with a reduced incidence of diabetes, and many randomized controlled trials have reported that daily consumption of GT can enhance oral glucose tolerance in healthy people and reduce fasting blood glucose and glycated hemoglobin levels in people at risk of diabetes. Lu'an Guapian (LAGP) belongs to the category of green tea and is produced in Lu'an, Anhui. It is one of the top ten famous teas in China. It has a long history and profound cultural connotations. It is deeply loved by consumers and has the effect of improving lipid metabolism disorders.
[0004] Cassia seed (CS) is one of the food and drug homologous substances approved by the National Health Commission. It has anti-hyperlipidemia and liver protection effects, and reduces total cholesterol and triglycerides in the serum of hyperlipidemia models. In modern clinical Chinese medicine, Cassia seed has been widely used to treat hyperlipidemia and diabetes. A study did not observe any adverse reactions related to treatment after a subchronic toxicity assessment of Cassia seed ethanol extract, indicating that the extract is relatively safe.
[0005] Lycium barbarum (LB) contains a variety of bioactive compounds, which are distributed in various layers of the peel and seeds, especially the exocarp and endocarp of drupes, mainly including polysaccharides, phenolic compounds, carotenoids, fatty acids, proteins, organic acids (citric acid, oxalic acid, etc.), vitamins, minerals and terpenes. At present, the research on the effect and mechanism of Lycium barbarum intervention on liver diseases focuses on relieving oxidative stress, inhibiting inflammation, anti-apoptosis and regulating lipid metabolism. Betaine in Lycium barbarum can inhibit fatty acid-induced fatty acid synthesis in HepG2 cells, stimulate fatty acid oxidation and lipid secretion, promote mitochondrial content and activity, and thus regulate lipid and energy metabolism.
[0006] At present, Lu'an Guapian, Cassia seed and Lycium barbarum can all be used as dietary supplements alone, and all have the effect of weight loss or lowering blood sugar. However, there is still a lack of systematic research on the prevention and treatment of metabolic syndrome (lowering blood sugar, lowering blood lipids and weight loss, and protecting blood vessels) using the above three herbs alone. There are also few reports on the combined use of the three, and the development of related functional products is still in its infancy.
[0007] The Chinese patent application document with publication number CN106070810A discloses a Liu'an Guapian with blood pressure lowering effect and its preparation method, which belongs to the technical field of Liu'an Guapian. The Liu'an Guapian is made of the following ingredients by weight: 28-32 parts of Liu'an Guapian, 5-7 parts of wild chrysanthemum, 10-12 parts of selfheal, 7-9 parts of apocynum leaves, 4-5 parts of cassia seeds, 2-4 parts of white sugar, 11-13 parts of wolfberry and 6-8 parts of enhancer. It has a blood pressure lowering effect, and long-term drinking can lower blood pressure; it is a pure natural product, has no toxic side effects, and can be drunk for a long time; it has the effects of clearing away heat and detoxification, diuresis and relieving fatigue.
[0008] The Chinese patent application document with publication number CN104783268A discloses a cassia seed and wolfberry oral liquid and a preparation method thereof, which relates to the field of health drinks. The method comprises the following steps: firstly, weighing cassia seed, adding pure water to soak for 1 hour, adding casein sodium, pulping and filtering without precipitation to obtain cassia seed pulp; weighing wolfberry dried fruit, adding pure water to soak for 12 hours, adding casein sodium and soy lecithin, pulping and filtering without precipitation to obtain wolfberry pulp; putting cassia seed pulp and wolfberry pulp into a homogenizer, adding xanthan gum for homogenization; sterilizing and filling the homogenized solution to prepare cassia seed and wolfberry oral liquid. The method has a high extraction rate of active ingredients in cassia seed and wolfberry, and the product has a good health effect.
[0009] The above patents use a mixture of multiple raw materials or only use two of them, and do not disclose the combined use of three raw materials, Lu'an Guapian, Cassia seed and Lycium barbarum, to prepare a fixed tea beverage with blood sugar and lipid lowering effects according to the present invention. Summary of the invention
[0010] The technical problem to be solved by the present invention is how to provide a composite tea with blood sugar and lipid lowering effects and its application in preparing food and health products for preventing glucose and lipid metabolism disorders.
[0011] The present invention solves the above technical problems through the following technical means:
[0012] The first aspect of the present invention provides a method for preparing a composite tea solid beverage, comprising the following steps:
[0013] (1) crushing and sieving Lu'an Guapian, Cassia seed and wolfberry in a weight ratio of (1-3):1:(1-3), and mixing them to obtain a mixture;
[0014] (2) Add water to the mixture, heat to reflux at 80-90° C. for 50-70 min, filter, concentrate, and freeze-dry to obtain the product.
[0015] Beneficial effects: The composite tea solid beverage prepared by the present invention, after Lu'an Guapian, Cassia seed and wolfberry are used in combination according to a certain ratio, has a better effect of lowering blood sugar and blood lipids, and has a better, more comprehensive and effective effect on the prevention and treatment of glucose and lipid metabolism disorders.
[0016] Preferably, the weight ratio of Lu'an Guapian, Cassia seed and Lycium barbarum is 2:1:1 or 1:1:2.
[0017] Preferably, the screening is specifically: screening through a 60-100 mesh sieve.
[0018] Preferably, the material-liquid ratio of the mixture to water is 1 g:(15-25) mL; more preferably, it is 1 g:20 mL.
[0019] The second aspect of the present invention provides a composite tea solid beverage prepared by the above preparation method.
[0020] The third aspect of the present invention provides the use of the above-mentioned composite tea solid beverage in the preparation of foods, medicines or health products for lowering blood sugar and / or blood lipids.
[0021] The fourth aspect of the present invention provides a product having the effect of lowering blood sugar and / or blood lipids, which comprises the above-mentioned composite tea solid beverage.
[0022] Preferably, the product includes one or more of food, medicine, and health care products.
[0023] Preferably, the product is a medicine, which further contains a pharmaceutically acceptable carrier.
[0024] Preferably, the pharmaceutically acceptable carrier is selected from one or more of a diluent, an excipient, a filler, a binder, a wetting agent, a disintegrant, an absorption promoter, a surfactant, an adsorption carrier and a lubricant.
[0025] Preferably, it is prepared into a pharmaceutically acceptable dosage form.
[0026] Preferably, the dosage form is tablet, powder, granule, pill, paste, capsule, oral solution or granule.
[0027] The advantages of the present invention are:
[0028] 1. The present invention compounds Lu'an Guapian, Cassia seed and Lycium barbarum in a scientific proportion, and the combined use has better effects on lowering blood sugar and blood lipids.
[0029] 2. The compound tea provided by the present invention is a natural green product, which is easy to use, safe and effective.
[0030] 3. The product produced by the present invention has higher nutritional value. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 This is a graph showing the inhibitory effect of different concentrations of substances in the present invention on the blood sugar-related index α-amylase, where LAGP is Lu'an Guapian, CS is Cassia Seed, LB is Lycium barbarum, and Ab is acarbose positive control. Different letters "ac" represent significant differences between different groups at the same concentration;
[0032] Figure 2 This is a graph showing the inhibitory effect of different ratios of combined intervention on the blood sugar-related index α-amylase, where 1:1:1, 1:1:2, 1:2:1, and 2:1:1 are all different ratios of Lu'an Guapian Cassia Seed and Wolfberry; *** represents p < 0.001 compared with 1:1:2, ** represents p < 0.01 compared with 1:1:2, and * represents p < 0.1 compared with 1:1:2;
[0033] Figure 3 The effect of each group of substances and combined intervention on glucose consumption of HepG2 cells induced by palmitic acid-induced insulin resistance. Among them, 1:1:1, 1:1:2, 1:2:1, and 2:1:1 are all different ratios of Lu'an Guapian Cassia Seed and Wolfberry; *** represents p < 0.001 compared with the model group, ** represents p < 0.01 compared with the model group, * represents p < 0.1 compared with the model group, and ns represents no significant difference compared with the model group;
[0034] Figure 4The effect of each group of substances and combined intervention on the glycogen synthesis ability of HepG2 cells induced by palmitic acid-induced insulin resistance. Among them, 1:1:1, 1:1:2, 1:2:1, and 2:1:1 are all different ratios of Lu'an Guapian Cassia Seed and Lycium Barbarum, the same below; *** represents p < 0.001 compared with the model group, ** represents p < 0.01 compared with the model group, * represents p < 0.1 compared with the model group, and ns represents no significant difference compared with the model group;
[0035] Figure 5 This is a graph showing the inhibitory effects of different concentrations of substances on pancreatic lipase, a lipid-related indicator. LAGP is Lu'an Guapian, CS is Cassia seed, and LB is Lycium barbarum. Different letters "ac" represent significant differences between different groups at the same concentration.
[0036] Figure 6 This is a graph showing the inhibitory effect of different ratios of substances combined intervention on pancreatic lipase, a lipid-related index. 1:1:1, 1:1:2, 1:2:1, and 2:1:1 are all different ratios of Lu'an Guapian Cassia Seed and Wolfberry; *** represents p < 0.001 compared with 1:1:2, ** represents p < 0.01 compared with 1:1:2, and * represents p < 0.1 compared with 1:1:2;
[0037] Figure 7 The effect diagram of each group of substances and combined intervention on palmitic acid-induced insulin resistance triglyceride in HepG2 cells. Among them, 1:1:1, 1:1:2, 1:2:1, and 2:1:1 are all different ratios of Lu'an Guapian Cassia Seed and Lycium Barbarum; *** represents p < 0.001 compared with the model group, ** represents p < 0.01 compared with the model group, * represents p < 0.1 compared with the model group, and ns represents no significant difference compared with the model group;
[0038] Figure 8 The changes in lipid droplet aggregation in insulin-resistant HepG2 cells caused by each group of substances and combined intervention. DETAILED DESCRIPTION
[0039] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described in combination with the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0040] Unless otherwise specified, the test materials and reagents used in the following examples can be obtained from commercial sources.
[0041] If no specific techniques or conditions are specified in the examples, they can be carried out according to the techniques or conditions described in the literature in the art or according to the product instructions.
[0042] A composite tea comprises the following components in parts by weight: 40-60 parts of Lu'an Guapian, 20-30 parts of Cassia seeds and 20-30 parts of Lycium barbarum; 20-30 parts of Lu'an Guapian, 20-30 parts of Cassia seeds and 40-60 parts of Lycium barbarum.
[0043] In the present invention, the preparation method of the composite tea comprises: respectively crushing Lu'an Guapian, Cassia seed and wolfberry and passing them through an 80-mesh sieve, and then extracting, filtering, concentrating, freeze-drying, packaging and other processes to produce a solid beverage for mixing with the effect of lowering blood sugar and lipid.
[0044] The present invention also provides the use of the composite tea in preparing foods and health products for preventing sugar and lipid metabolism. Specifically, the prevention of sugar and lipid metabolism disorders includes lowering blood sugar and blood lipids.
[0045] In the present invention, the food or health care product can be various dosage forms known in the art, including but not limited to tablets, powders, granules, oral liquids, etc. In the present invention, in addition to the composite tea, the food or health care product can also include auxiliary materials of food or health care products. The technical solution provided by the present invention is described in detail below in conjunction with the embodiments, but they cannot be understood as limiting the scope of protection of the present invention.
[0046] Embodiment 1:
[0047] A method for preparing a composite tea solid beverage comprises the following steps:
[0048] (1) Crush Lu'an Guapian, Cassia seed, and Lycium barbarum in a weight ratio of 1:1:2, pass through an 80-mesh sieve, and mix to obtain a mixture;
[0049] (2) Add water to the mixture, wherein the ratio of solid to liquid is 1 g:20 mL, heat to reflux at 85° C. for 60 min, filter, concentrate, and freeze-dry to obtain the product.
[0050] Embodiment 2:
[0051] The difference between this embodiment and embodiment 1 is that the weight ratio of Lu'an Guapian, Cassia seed and Lycium barbarum is 2:1:1, and the other steps are the same as those in embodiment 1.
[0052] Embodiment 3:
[0053] The difference between this embodiment and embodiment 1 is that the weight ratio of Lu'an Guapian, Cassia seed and Lycium barbarum is 1:1:1, and the other steps are the same as those in embodiment 1.
[0054] Embodiment 4:
[0055] The difference between this embodiment and embodiment 1 is that the weight ratio of Lu'an Guapian, Cassia seed and Lycium barbarum is 1:2:1, and the other steps are the same as those in embodiment 1.
[0056] Performance test of composite teas with different proportions prepared from Lu'an Guapian (LAGP), Cassia Seed (CS), Lycium barbarum (LB) and Examples 1 to 4
[0057] 1. Inhibition of α-amylase:
[0058] Increased blood sugar is closely related to α-amylase, which can hydrolyze carbohydrates such as starch into oligosaccharides, while α-glucosidase further degrades glucose into oligosaccharides. Inhibiting α-amylase is one of the main strategies to combat hyperglycemia and type 2 diabetes.
[0059] The samples of Lu'an Guapian, Cassiae and Lycium barbarum were prepared into 0.625, 1.25, 2.5 and 5.0 mg / mL sample solutions with 0.1 mol / mL phosphate buffer (PBS; pH 6.8), 0.4 mL of sample solution was added with 0.2 mL of 1% starch solution (prepared with 0.1 mol / mL PBS, pre-warmed), and the solution was bathed in 40°C water for 5 min, and then 0.2 mL of 0.5 mg / mL α-amylase solution (3700 U / mg) (prepared with 0.1 mol / mL PBS) was added, and the solution was bathed in 40°C water for 10 min, and then 0.4 mL of DNS was added, and the solution was bathed in 95°C boiling water for 4 min, and then iced immediately, and the absorbance value was measured at 540 nm. Acarbose was used as the positive control group.
[0060] Depend on Figure 1 It can be seen that Lu'an Guapian, Cassiae and Lycium barbarum have a certain inhibitory effect on α-amylase, and have a certain dose-effect relationship. When the concentration is 5 mg / mL (the concentration of different ratios of compound tea refers to the concentration of the mixture, for example, to prepare 5 mg / mL: weigh 10g of Lu'an Guapian, 5g of Cassiae, 5g of Lycium barbarum, the material-liquid ratio is 1g:20mL, add 400mL of water to extract at 85°C for 60min, filter, concentrate, freeze-dry to obtain its freeze-dried powder, weigh 5g of the compound freeze-dried powder, add 1mL of water to prepare), the inhibition rates of Lu'an Guapian, Cassiae, Lycium barbarum and acarbose on α-amylase are 38.49%, 20.32%, 76.84% and 78.89% respectively; at a concentration of 2.5 mg / mL, the inhibition rate of Lu'an Guapian: Cassiae: Lycium barbarum = 1:1:2 is the highest, with a rate of 60.10%, and there is a significant difference with other dosage groups (such as Figure 2 shown).
[0061] 2. Effects on glucose consumption in palmitic acid-induced insulin-resistant HepG2 cells:
[0062] In a normal body, cells use insulin to break down glucose to provide energy for the body. When the body develops insulin resistance, cells become less sensitive to insulin, resulting in a decrease in the amount of glucose that cells take in. Using drugs that improve insulin resistance will increase the amount of glucose that cells consume, thereby achieving a blood sugar-lowering effect.
[0063] The cell concentration was adjusted to 5 × 10 4 / mL, cells were inoculated in 24-well plates, 1mL per well. After the cells adhered, the original complete medium was discarded, washed twice with PBS, and serum-free medium was added for starvation for 12h, 1mL per well. After the cells were in the same state, the original medium was discarded, and the HepG2 cells were acted on with a medium containing 5% FBS containing 0.25mM palmitic acid for 24h. The experimental groups were as follows:
[0064] Blank control group (5% FBS medium),
[0065] Normal cell control group (5% FBS medium),
[0066] Model cell group (0.25 mM palmitate + 5% FBS culture medium).
[0067] Lu'an Guapian water extract, Cassia water extract, Lycium barbarum water extract 25μg / mL, and mixed water extract (Lu'an Guapian: Cassia: Lycium barbarum = 1:1:1, Lu'an Guapian: Cassia: Lycium barbarum = 1:2:1, Lu'an Guapian: Cassia: Lycium barbarum = 1:1:2, Lu'an Guapian: Cassia: Lycium barbarum = 2:1:1) 25μg / mL, 6 replicates per group, discard the original culture medium after 24h, wash twice with PBS, add serum-free, phenol red-free, high-glucose DMEM culture medium to each well, take 2μL of culture medium from each well after 2min, use glucose oxidase kit to determine the residual sugar content of the culture medium, 200μL per well, put in 37℃ incubator for 30min, and detect the absorbance at 505nm. The effect of each group on the glucose consumption of IR-HepG2 cells is shown in Figure 3 shown.
[0068] Compared with the normal group, the glucose consumption of the model group cells was significantly reduced; compared with the model group, the glucose consumption of LAGP, CS, and LB cells was significantly increased. This shows that LAGP, CS, and LB can effectively increase the glucose consumption of IR-HepG2 cells, and the glucose consumption of the compound intervention group Lu'an Guapian: Cassia: Lycium barbarum = 1:1:2 intervention was the highest, and the intervention effect was the best compared with other different ratio groups and Lu'an Guapian, Cassia, Lycium barbarum group.
[0069] 3. Effects on glycogen synthesis in palmitic acid-induced insulin-resistant HepG2 cells:
[0070] Cells take up glucose and synthesize glycogen through the action of various enzymes. The synthesis and decomposition of glycogen are extremely important for maintaining blood sugar balance.
[0071] The cell concentration was adjusted to 5 × 10 4 / mL, cells were inoculated in 24-well plates, 1mL per well. After the cells adhered, the original complete medium was discarded, washed twice with PBS, and serum-free medium was added for starvation for 12h, 1mL per well. After the cells were in the same state, the original medium was discarded, and the HepG2 cells were acted on with a medium containing 5% FBS containing 0.25mM palmitic acid for 24h. The experimental groups were as follows:
[0072] Blank control group (5% FBS medium),
[0073] Normal cell control group (5% FBS medium),
[0074] Model cell group (0.25 mM palmitate + 5% FBS culture medium).
[0075] Liuan Guapian water extract, Cassia water extract, Lycium barbarum water extract 25 μg / mL, and mixed water extract (Liuan Guapian: Cassia: Lycium barbarum = 1:1:1, Liuan Guapian: Cassia: Lycium barbarum = 1:2:1, Liuan Guapian: Cassia: Lycium barbarum = 1:1:2, Liuan Guapian: Cassia: Lycium barbarum = 2:1:1) 25 μg / mL, 6 replicates per group, discard the original culture medium after 24 hours, wash twice with PBS, add trypsin to each well for digestion, then add culture medium to terminate digestion, transfer the culture medium containing cells in each well to EP tube, centrifuge and discard the supernatant, resuspend and wash twice with PBS, centrifuge and discard the supernatant. Add 500 μL of extract to each tube and ultrasonically disrupt the cells (power 20%, ultrasonic 3s, interval 10s, repeat 30 times); transfer to a 10mL test tube, place in a 95℃ water bath for 20min, plug the tube mouth with a rubber stopper to prevent water loss, and shake the test tube once every 5min to mix thoroughly; take out the test tube and cool it, then dilute to 1mL with distilled water, mix well, centrifuge at 8000rpm25℃ for 10min, and take the supernatant to measure the absorption wavelength at 620nm
[0076] The effects of each group on glycogen synthesis in IR-HepG2 cells are shown in Figure 4 The glycogen content of IR-HepG2 cells treated with LAGP, CS and LB was significantly increased. Compared with LAGP and CS, LB had the best intervention effect, followed by LAGP and CS. Compared with the same concentration and different ratios of Lu'an Guapian, Cassia seed and Lycium barbarum, the intervention effect of Lu'an Guapian: Cassia seed: Lycium barbarum = 1:1:2 was the best.
[0077] 4. Inhibition of pancreatic lipase:
[0078] Lipase, a common enzyme in the human body, can hydrolyze triglycerides in food into glycerol and free fatty acids, which are then absorbed by the small intestine and resynthesized into triglycerides, resulting in a large accumulation of lipids in the body that are not metabolized and excreted. Therefore, in the evaluation of high-efficiency lipid-lowering effects in vitro, the inhibition rate of lipase is often used as a criterion.
[0079] Accurately weigh 0.01g of the three extracts of Lu'an Guapian, Cassia Seed and Lycium Barbarum into each beaker and dissolve them in water. Transfer to a 10mL volumetric flask and make up to volume, so that the concentration of the sample is 5000μg / mL. Place in a 4℃ refrigerator for later use. Accurately pipette 50μL of sample solutions of different concentrations (625, 1250, 2500, 5000μg / mL) into a test tube, and then add 150μL of porcine pancreatic lipase solution and 350μL of buffer solution respectively, preheat at 37℃ for 10min, then add 450μL of substrate solution, mix thoroughly and place in a 37℃ oven for reaction for 2h. Subsequently, centrifuge at 12000rpm for 10min, take the supernatant, and measure the absorbance at 405nm. Three parallels are used in each group. The control group uses buffer instead of enzyme solution
[0080] The inhibitory effects of water extracts of Lu'an Guapian, Cassiae and Lycium barbarum on lipase at different concentrations Figure 5 As shown. Figure 5 It can be seen that at a certain concentration, the three extracts all have a certain inhibitory activity on pancreatic lipase. When the concentration is ≥1.25mg / mL, each group shows a certain inhibitory effect on pancreatic lipase; when the concentration is higher than 1.25mg / mL, the Lu'an Guapian group has a certain inhibitory activity on pancreatic lipase; and compared with the other two groups, the inhibition rate is the highest. At the same time, with the increase of concentration, the inhibition rate also gradually increases, indicating that it has a certain dose-effect relationship. Figure 6 It shows that when the ratio of Lu'an Guapian to Cassia to Wolfberry is 2:1:1, the inhibition rate of pancreatic lipase is the highest, reaching 25.01%, which is significantly different from other groups.
[0081] 5. Effects of palmitic acid on triglycerides in insulin-resistant HepG2 cells:
[0082] Insulin resistance is also associated with overproduction of triglycerides (TG).
[0083] The cell concentration was adjusted to 5 × 10 4 / mL, cells were inoculated in 24-well plates, 1mL per well. After the cells adhered, the original complete medium was discarded, washed twice with PBS, and serum-free medium was added for starvation for 12h, 1mL per well. After the cells were in the same state, the original medium was discarded, and the HepG2 cells were acted on with a medium containing 5% FBS containing 0.25mM palmitic acid for 24h. The experimental groups were as follows:
[0084] Blank control group (5% FBS medium),
[0085] Normal cell control group (5% FBS medium),
[0086] Model cell group (0.25 mM palmitate + 5% FBS culture medium).
[0087] Liuan Guapian water extract, Cassia water extract, Lycium barbarum water extract 25 μg / mL, and mixed water extract (Liuan Guapian: Cassia: Lycium barbarum = 1:1:1, Liuan Guapian: Cassia: Lycium barbarum = 1:2:1, Liuan Guapian: Cassia: Lycium barbarum = 1:1:2, Liuan Guapian: Cassia: Lycium barbarum = 2:1:1) 25 μg / mL, 6 replicates per group, discard the original culture medium after 24 hours, wash twice with PBS, after 24 hours of drug treatment, discard the original culture medium, wash twice with pre-cooled PBS, add 150 μL RIPA lysis buffer to each well, centrifuge after 1-2 seconds, and take the supernatant for triglyceride detection.
[0088] Compared with the normal cell group, the TG content of the model group was significantly increased (p < 0.01). Compared with the model group, the triglyceride content of IR-HepG2 cells treated with LAGP, CS, and LB was significantly reduced; compared with CS and LB, LAGP had the best intervention effect, followed by CS, and LB was the worst; compared with the same concentration and different ratios of Lu'an Guapian, Cassia seed, and Lycium barbarum, Lu'an Guapian: Cassia seed: Lycium barbarum = 2:1:1 had the best intervention effect. (such as Figure 7 shown.)
[0089] 6. Effects on palmitic acid-induced insulin resistance and fat accumulation in HepG2 cells:
[0090] The cell concentration was adjusted to 5 × 10 4 / mL, cells were inoculated in 24-well plates, 1mL per well. After the cells adhered, the original complete medium was discarded, washed twice with PBS, and serum-free medium was added for starvation for 12h, 1mL per well. After the cells were in the same state, the original medium was discarded, and the HepG2 cells were acted on with a medium containing 5% FBS containing 0.25mM palmitic acid for 24h. The experimental groups were as follows:
[0091] Blank control group (5% FBS medium),
[0092] Normal cell control group (5% FBS medium),
[0093] Model cell group (0.25 mM palmitate + 5% FBS culture medium).
[0094] Lu'an Guapian water extract, Cassia water extract, Lycium barbarum water extract 25μg / mL, and mixed water extract (Lu'an Guapian: Cassia: Lycium barbarum = 1:1:1, Lu'an Guapian: Cassia: Lycium barbarum = 1:2:1, Lu'an Guapian: Cassia: Lycium barbarum = 1:1:2, Lu'an Guapian: Cassia: Lycium barbarum = 2:1:1) 25μg / mL, 6 replicates per group, 24h later, discard the original culture medium, wash twice with PBS, after 24h of drug treatment, discard the original culture medium, add 1mL of PBS solution to each well to rinse the cells twice, then add 4% paraformaldehyde to each well for fixation for 30min. After fixation, add 1mL of PBS to each well to rinse the cells twice, then add 1mL of 60% isopropanol to each well for immersion. Discard the isopropanol, add Oil Red O staining solution to each well, stain for 30min; discard Oil Red O and add 60% isopropanol for immersion. Discard the isopropanol, add 1 mL of pure water to each well, and observe and take pictures under a microscope. Figure 8 The results showed that only a small amount of tiny lipid droplets were aggregated in the HepG2 cells of the normal group; while a large amount of lipid droplets were aggregated in the cells of the model group, and more serious fatty degeneration occurred; after the action of LAGP, CS, and LB in the intervention group, the model cells began to show a clearing effect on lipid deposition; in the water extracts of different ratios, it can be seen that the lipid droplet aggregation was the least in the ratio of Lu'an Guapian: Cassia seed: Lycium barbarum = 2:1:1, indicating that compared with other different ratios, Lu'an Guapian: Cassia seed: Lycium barbarum = 2:1:1 had the best effect.
[0095] Embodiment 5:
[0096] A method for preparing a composite tea solid beverage comprises the following steps:
[0097] (1) Crush Lu'an Guapian, Cassia seed, and Lycium barbarum in a weight ratio of 3:1:3, pass through a 60-mesh sieve, and mix to obtain a mixture;
[0098] (2) Add water to the mixture, wherein the ratio of solid to liquid is 1 g:15 mL, heat to reflux at 80° C. for 70 min, filter, concentrate, and freeze-dry to obtain the product.
[0099] Embodiment 6:
[0100] A method for preparing a composite tea solid beverage comprises the following steps:
[0101] (1) Crush Lu'an Guapian, Cassia seed, and Lycium barbarum in a weight ratio of 2:1:2, pass through a 100-mesh sieve, and mix to obtain a mixture;
[0102] (2) Add water to the mixture, wherein the ratio of solid to liquid is 1 g:25 mL, heat to reflux at 90° C. for 50 min, filter, concentrate, and freeze-dry to obtain the product.
[0103] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for preparing a composite tea solid beverage, characterized in that: The following steps are involved: (1) crushing and sieving Lu'an Guapian, Cassia seed and wolfberry in a weight ratio of (1-3):1:(1-3), and mixing them to obtain a mixture; (2) Add water to the mixture, heat to reflux at 80-90° C. for 50-70 min, filter, concentrate, and freeze-dry to obtain the product.
2. The method for preparing the composite tea solid beverage according to claim 1, characterized in that: The weight ratio of Lu'an Guapian, Cassia seed and Lycium barbarum is 2:1:1 or 1:1:
2.
3. The method for preparing the composite tea solid beverage according to claim 1, characterized in that: The material-liquid ratio of the mixture to water is 1g:(15-25)mL.
4. A composite tea solid beverage prepared by the preparation method according to any one of claims 1 to 3.
5. Use of the composite tea solid beverage prepared by the preparation method according to any one of claims 1 to 3 in the preparation of foods, medicines or health products for lowering blood sugar and / or blood lipids.
6. A product with the effect of lowering blood sugar and / or blood lipid, characterized in that: It comprises the composite tea solid beverage according to claim 4; the product comprises one or more of food, medicine and health care product.
7. The product having the effect of lowering blood sugar and / or blood lipid according to claim 6, characterized in that: The product is a medicine, which also contains a pharmaceutically acceptable carrier.
8. The product having the effect of lowering blood sugar and / or blood lipid according to claim 6, characterized in that: The pharmaceutically acceptable carrier is selected from one or more of a diluent, an excipient, a filler, a binder, a wetting agent, a disintegrant, an absorption promoter, a surfactant, an adsorption carrier and a lubricant.
9. The product having the effect of lowering blood sugar and / or blood lipid according to claim 7, characterized in that: Prepared into pharmaceutically acceptable dosage forms.
10. The product having the effect of lowering blood sugar and / or blood lipid according to claim 9, characterized in that: The dosage form is tablet, powder, granule, pill, paste, capsule, oral liquid or granule.
Citation Information
Patent Citations
Guapian tea bag
CN105875931A
Liu'an Guapian tea with blood pressure reducing effect and preparation method thereof
CN106070810A
